Evaluating Ventricular Arrhythmia in Subjects With Implantable

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator — TEMPO

Ventricular Arrhythmia Clinical Trial

Official title:
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging, Parallel Group Study to Evaluate the Effect of GS-6615 on Ventricular Arrhythmia in Subjects With Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronization Therapy-Defibrillator (CRT-D)

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the effect of eleclazine (GS-6615) compared to placebo on the overall occurrence of appropriate implantable cardioverter-defibrillator (ICD) interventions (antitachycardia pacing [ATP] or shock) in adults with ICD or cardiac resynchronization therapy-defibrillator (CRT-D).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Ventricular Arrhythmia

Clinical Trial Details

NCT number	NCT02104583
Study type	Interventional
Source	Gilead Sciences
Contact
Status	Completed
Phase	Phase 2
Start date	September 2014
Completion date	October 2016

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01281241` - Study on Mechanical and Electrical Alternans	N/A
Completed	`NCT00993382` - Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death	Phase 2
Completed	`NCT00000504` - Cardiac Arrhythmia Pilot Study (CAPS)	Phase 2
Recruiting	`NCT06048731` - Enlighten Study: The EV-ICD Post Approval Registry
Terminated	`NCT02114528` - Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention	Phase 4
Completed	`NCT05099289` - Parasternal Access for ShockS and Pacing With an acUtely Placed Less-invasive Lead for EV-ICD (PASS PULL EV-ICD) Study	N/A
Completed	`NCT05352776` - Sensing and Defibrillation With a Commercially Available ICD Coupled With a Parasternal Extravascular Lead (SECURE EV) Study	N/A
Recruiting	`NCT01999140` - Implantable Cardioverter Defibrillator (ICD Registry)
Completed	`NCT02088619` - Positive Therapy for Autonomic Function & Mood in ICD Patients	N/A
Completed	`NCT00064558` - Genetic Determinants of Sudden Cardiac Death
Completed	`NCT00000518` - Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)	Phase 3
Completed	`NCT00102180` - Drug-Induced Sudden Death & Ventricular Arrhythmia
Completed	`NCT00006501` - Prognostic Significance of T Wave Alternans	N/A
Completed	`NCT01804439` - Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes	N/A
Completed	`NCT02881255` - Avoid Transvenous Leads in Appropriate Subjects	N/A
Completed	`NCT00000540` - Coronary Artery Bypass Graft (CABG) Patch Trial	Phase 3
Completed	`NCT00005235` - Heart Rate Variability and Sudden Cardiac Death	N/A
Completed	`NCT00005197` - Predictors of Perioperative Cardiac Morbidity	N/A
Enrolling by invitation	`NCT04520347` - IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
Completed	`NCT00000526` - Cardiac Arrhythmia Suppression Trial (CAST)	Phase 3